SITE UNDER CONSTRUCTION
STAY TUNED FOR FURTHER DEVELOPMENTS
"Welcome, and thank you for participating in this important survey regarding the availability, implementation, and perception of Medication-Assisted Treatment (MAT)—also referred to as Medications for Opioid Use Disorder (MOUD)—within correctional facilities.
Substance use disorders heavily impact incarcerated populations, and evidence-based treatments like methadone, buprenorphine, and naltrexone are proven to reduce post-release overdose risks and support long-term recovery. This survey aims to identify current operational practices, existing resource barriers, and opportunities for care expansion within our prison system. Your candid, professional insights are completely confidential and vital to shaping safe, effective healthcare and reentry protocols."
Substance use disorders heavily impact incarcerated populations, and evidence-based treatments like methadone, buprenorphine, and naltrexone are proven to reduce post-release overdose risks and support long-term recovery. This survey aims to identify current operational practices, existing resource barriers, and opportunities for care expansion within our prison system. Your candid, professional insights are completely confidential and vital to shaping safe, effective healthcare and reentry protocols."
